Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP7 | P09237 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.33 |
| ▸ | ACE | P12821 | 3/20 | 0.33 |
| ▸ | CPB1 | P15086 | 1/20 | 0.33 |
| ▸ | REN | P00797 | 1/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | ECE1 | P42892 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29429284 | 0.98 | SLC15A2 (0.40) | SLC15A2MMP2MMP7MMP9MMP12 | |
| SCHEMBL29590377 | 0.94 | SLC15A2 (0.40) | SLC15A2MMEECE1 | |
| SCHEMBL29590566 | 0.92 | SLC15A2 (0.49) | SLC15A2CPB2CPB1MME | |
| SCHEMBL20783813 | 0.92 | SLC15A2 (0.49) | SLC15A2CPB2CPB1MME | |
| SCHEMBL31453803 | 0.92 | SLC15A2 (0.49) | SLC15A2CPB2CPB1MME | |
| SCHEMBL29591894 | 0.92 | SLC15A2 (0.41) | SLC15A2 | |
| SCHEMBL29626709 | 0.90 | ACE (0.44) | ACEMMECPA1ACE2 | |
| SCHEMBL29591786 | 0.90 | SLC15A2 (0.41) | SLC15A2 | |
| SCHEMBL31443168 | 0.88 | CTSD (0.40) | SLC15A2REN | |
| SCHEMBL29630538 | 0.88 | OPRD1 (0.38) | SLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |